- Home
- OBIO vs AFRI Comparison
OBIO vs AFRI Comparison
Compare OBIO & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | AFRI |
|---|---|---|
| Founded | 2017 | 1943 |
| Country | United States | Gibraltar |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 235.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OBIO | AFRI |
|---|---|---|
| Price | $4.19 | $10.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 202.4K | 22.8K |
| Earning Date | 11-10-2025 | 01-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,818,000.00 | ★ $274,223,000.00 |
| Revenue This Year | $35.75 | N/A |
| Revenue Next Year | $3.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $2.20 | $7.47 |
| 52 Week High | $6.30 | $11.42 |
Technical Indicators
Market Signals| Indicator | OBIO | AFRI |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 55.52 |
| Support Level | $4.07 | $10.41 |
| Resistance Level | $4.37 | $11.42 |
| Average True Range (ATR) | 0.25 | 0.47 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 16.80 | 37.61 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.